The immune system provides constant surveillance for the body, aiming to spot and eliminate disease-causing microbes or ...

HIGH-fat diets have been linked to the UK’s fastest growing cancer – whose subtle symptoms may at first be mistaken for the ...

One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...

Gastric cancer cells can activate KRAS-driven signals, enabling autonomous tumor growth by producing their own WNT proteins. New research reveals how gastric cancer cells exploit WNT signaling for ...

A newly identified and rare genetic variant slows the growth of mutated blood stem cells and reduces the risk of leukemia.

The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...

Gallbladder cancer is a rare and often aggressive malignancy that develops in the tissues of the gallbladder — a small, ...

At 47, Todd Leach learned he carries a genetic mutation that significantly raised his risk for a rare stomach cancer. He had ...

Advancements in understanding tumor biology, identifying predictive biomarkers, and developing targeted therapies have ...

Twelve months later, Miller is healthy and preparing to host her family's holiday gathering. A regimen of biological drugs ...

The drug is not considered a cure, but results from clinical trials point to major advancement for a devastating cancer ...

Molecular ESR1 changes may signal symptomatic progression before imaging in metastatic breast cancer, supporting camizestrant for improved quality of life.